Cargando…
Efficacy and tolerability of EPs 7630 in patients (aged 6–18 years old) with acute bronchitis
AIM: For EPs-7630, a herbal drug preparation from Pelargonium sidoides roots, therapeutic effects in respiratory tract infections outside the strict indication for antibiotics have already been demonstrated in adults. Now, a dose-finding study for EPs-7630 was performed in children and adolescents....
Autores principales: | Kamin, W, Maydannik, VG, Malek, FA, Kieser, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855831/ https://www.ncbi.nlm.nih.gov/pubmed/20070280 http://dx.doi.org/10.1111/j.1651-2227.2009.01656.x |
Ejemplares similares
-
Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis
por: Kamin, Wolfgang, et al.
Publicado: (2023) -
Effects of EPs 7630 on the duration of inability to work in acute bronchitis – a meta-analysis
por: Matthys, Heinrich, et al.
Publicado: (2023) -
Faster recovery and reduced paracetamol use – a meta-analysis of EPs 7630 in children with acute respiratory tract infections
por: Seifert, Georg, et al.
Publicado: (2019) -
Evaluation of pharmacodynamic activities of EPs(®) 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis
por: Bao, Yanyan, et al.
Publicado: (2015) -
Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life – a meta-analysis of randomized, placebo-controlled trials
por: Kardos, Peter, et al.
Publicado: (2022)